Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney Sells 30,000 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) President Dawn Christine Maroney sold 30,000 shares of the business's stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $13.72, for a total transaction of $411,600.00. Following the sale, the president now owns 1,576,097 shares of the company's stock, valued at $21,624,050.84. This trade represents a 1.87 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link.

Dawn Christine Maroney also recently made the following trade(s):

• On Wednesday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $13.61, for a total transaction of $408,300.00.

Alignment Healthcare Stock Performance

Shares of NASDAQ ALHC traded down $1.21 during midday trading on Friday, hitting $13.17. 2,613,574 shares of the company's stock traded hands, compared to its average volume of 1,797,702. Alignment Healthcare, Inc. has a 1 year low of $4.46 and a 1 year high of $15.82. The stock has a market capitalization of $2.52 billion, a price-to-earnings ratio of -17.10 and a beta of 1.50. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60. The firm has a fifty day moving average of $13.19 and a 200 day moving average of $11.76.

Institutional Investors Weigh In On Alignment Healthcare

Several hedge funds and other institutional investors have recently made changes to their positions in ALHC. Mackenzie Financial Corp increased its holdings in Alignment Healthcare by 149.8% in the 4th quarter. Mackenzie Financial Corp now owns 85,175 shares of the company's stock worth $958,000 after acquiring an additional 51,084 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Alignment Healthcare by 15.9% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 263,203 shares of the company's stock worth $2,961,000 after purchasing an additional 36,151 shares during the period. Voloridge Investment Management LLC bought a new position in Alignment Healthcare in the 4th quarter worth approximately $189,000. Squarepoint Ops LLC boosted its stake in Alignment Healthcare by 414.6% in the 4th quarter. Squarepoint Ops LLC now owns 198,309 shares of the company's stock worth $2,231,000 after purchasing an additional 159,774 shares during the period. Finally, Two Sigma Investments LP bought a new position in Alignment Healthcare in the 4th quarter worth approximately $258,000. Hedge funds and other institutional investors own 86.19% of the company's stock.

Analysts Set New Price Targets

ALHC has been the topic of several research reports. Barclays lifted their price target on shares of Alignment Healthcare from $7.00 to $8.00 and gave the stock an "underweight" rating in a research note on Wednesday, October 30th. Stephens reissued an "overweight" rating and set a $17.00 price objective on shares of Alignment Healthcare in a research report on Thursday, January 2nd. Stifel Nicolaus boosted their price objective on shares of Alignment Healthcare from $14.00 to $16.00 and gave the company a "buy" rating in a research report on Tuesday, January 14th. Finally, UBS Group boosted their target price on shares of Alignment Healthcare from $9.00 to $12.00 and gave the company a "neutral" rating in a report on Wednesday, October 30th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $11.88.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.